Evidence map›Paper›PMID 38299238›Full record

ArticleInternational journal of molecular medicine2024

[Retracted] Antagonist targeting miR‑106b‑5p attenuates acute renal injury by regulating renal function, apoptosis and autophagy via the upregulation of TCF4.

Jing-Meng Hu, Li-Jie He, Peng-Bo Wang, Yan Yu, Ya-Ping Ye, Li Liang

Abstract readRetraction Notice
In one paragraph

Article in International journal of molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Jing-Meng HuDepartment of Pathology, The Southern Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Li-Jie HeDepartment of Nephrology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710000, P.R. China.
Peng-Bo WangDepartment of Nephrology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710000, P.R. China.
Yan YuDepartment of Nephrology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710000, P.R. China.
Ya-Ping YeDepartment of Pathology, The Southern Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Li LiangDepartment of Pathology, The Southern Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the EdU staining assay data shown in Figs. 4C and 5C and the western blotting data shown in Fig. 4E were strikingly similar to data appearing in different form in other research articles written by different authors at different research institutes that had either already been published, or were submitted for publication at around the same time. Owing to the fact that contentious data in the above article had already been submitted for publication elsewhere prior to its submission to

Indexed as

acute renal injuryischemia‑reperfusionmiR‑106b‑5ptranscription factor 4

Identifiers

PMID38299238
PMCPMC10852009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.